Our goal in this proposal is to investigate a novel strategy for female contraception that utilizes a new class of drugs, the Selective Estrogen Receptor Modulators (SERMs). SERMs are compounds that selectively regulate estrogen action in various tissues. Estrogen action is required for normal function of reproductive tract tissues. These functions include: the transport of spermatozoa to the site of fertilization in the fallopian tube;the capture of the oocyte by the fallopian tube after ovulation;the transport of the developing embryo to the uterus;and implantation of the embryo into the endometrium. Our hypothesis is that anti-estrogenic SERM therapy, targeting the reproductive tract, will result in a selective blockade of spermatozoa/oocyte transport and hence fertilization. Evidence for this possibility emanates from our observation that daily administration of a novel nonsteroidal SERM, ZK-SERM (Schering AG) blocked estrogen action in the rhesus macaque reproductive tract, resulting in atrophy of the cervical and endometrial mucosa, and suppression of oviductal ciliation and secretion. To test this hypothesis, we propose in Specific Aim 1 to examine whether therapy with ZK-SERM, our prototype SERM, will disrupt gamete transport and or fertilization in rhesus macaques. In additional experiments, we will examine morphological, biochemical and molecular endpoints within the reproductive tract that may participate in altered gamete transport and fertilization. We further hypothesize that SERMs, like ZK-SERM, that selectively block estrogen action in the reproductive tract, can provide a promising group of compounds for contraception.
In Specific Aim 2 we propose to demonstrate that SERM therapy will block fertility in cynomologus macaques during a contraceptive trial through the ONPRC Nonhuman Primate Contraceptive Core. We will then assess the reversibility of the SERM-based contraceptive effect.
In Specific Aim 3 we will assess the long-term effects of SERM treatment on ovarian function, menstrual cyclicity, bone mass and pelvic floor connective tissues. This research, """"""""at the end of the day"""""""" will provide a definitive assessment of the contraceptive potential of selective antiestrogenic SERM therapy targeting the reproductive tract. We will have a strong understanding of the effects of antiestrogenic SERM therapy on gamete transport and reproductive tract functions. In addition we will have data on the safety of SERM therapy. These data will provide a basis for new studies on the mechanisms of SERM action """"""""down stream"""""""" of estrogen receptor-ligand interactions in future studies.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HD055744-05
Application #
8232177
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
2012-08-31
Budget Start
2011-03-01
Budget End
2013-02-28
Support Year
5
Fiscal Year
2011
Total Cost
$289,810
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Slayden, Ov D; Lee, Dong Ock; Yao, Shan et al. (2016) Polidocanol induced tubal occlusion in nonhuman primates: immunohistochemical detection of collagen I-V. Contraception 94:521-526
Hanna, Carol B; Yao, Shan; Ramsey, Cathy M et al. (2015) Phosphodiesterase 3 (PDE3) inhibition with cilostazol does not block in vivo oocyte maturation in rhesus macaques (Macaca mulatta). Contraception 91:418-22
Jensen, Jeffrey T; Hanna, Carol; Yao, Shan et al. (2015) Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons. Contraception 92:96-102
Peluffo, M C; Stanley, J; Braeuer, N et al. (2014) A prostaglandin E2 receptor antagonist prevents pregnancies during a preclinical contraceptive trial with female macaques. Hum Reprod 29:1400-12
Edelman, Alison B; Jensen, Jeffrey T; Doom, Carmen et al. (2013) Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women. Contraception 87:352-7
Peluffo, Marina C; Hennebold, Jon D; Stouffer, Richard L et al. (2013) Oocyte maturation and in vitro hormone production in small antral follicles (SAFs) isolated from rhesus monkeys. J Assist Reprod Genet 30:353-9
Stouffer, Richard L; Bishop, Cecily V; Bogan, Randy L et al. (2013) Endocrine and local control of the primate corpus luteum. Reprod Biol 13:259-71
Micks, Elizabeth; Shekell, Taylor; Stanley, Jessica et al. (2012) Medical termination of pregnancy in cynomolgus macaques. J Med Primatol 41:394-402
Keator, Christopher S; Mah, Kuni; Slayden, Ov D (2012) Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis. Mol Hum Reprod 18:308-19
Hanna, Carol B; Yao, Shan; Wu, Xuemei et al. (2012) Identification of phosphodiesterase 9A as a cyclic guanosine monophosphate-specific phosphodiesterase in germinal vesicle oocytes: a proposed role in the resumption of meiosis. Fertil Steril 98:487-95.e1

Showing the most recent 10 out of 23 publications